1. Home
  2. MED vs UNCY Comparison

MED vs UNCY Comparison

Compare MED & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$10.88

Market Cap

120.6M

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.23

Market Cap

121.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MED
UNCY
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.6M
121.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MED
UNCY
Price
$10.88
$6.23
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$16.50
$44.50
AVG Volume (30 Days)
200.3K
446.3K
Earning Date
11-03-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$429,695,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$450.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.36
$3.71
52 Week High
$21.98
$11.00

Technical Indicators

Market Signals
Indicator
MED
UNCY
Relative Strength Index (RSI) 37.36 61.13
Support Level $10.72 $5.77
Resistance Level $11.12 $6.70
Average True Range (ATR) 0.33 0.41
MACD 0.07 0.05
Stochastic Oscillator 48.37 69.85

Price Performance

Historical Comparison
MED
UNCY

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: